Lymphomas in the Young and the Old: How Do They Differ?
Researchers examined how the molecular features of Hodgkin lymphomas differ between young and older patients.
Category: Awareness Months
Researchers examined how the molecular features of Hodgkin lymphomas differ between young and older patients.
New research improves physicians' “molecular chess” game against thyroid cancer to overcome resistance to treatments.
Researchers are making progress on genetic classification of sarcoma tumors, the use of T-cell therapy, and nanomedicine delivery.
LGBTQ+ cancer survivors offer lessons learned, and a researcher explains the odds of chronic conditions in LGBTQ+ survivors.
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
Researchers at the AACR Annual Meeting 2024 examined new treatment options for brain tumors.
Dan Theodorescu and Lars Dyrskjøt preview the AACR's upcoming conference on bladder cancer.
Three patients share their experiences about having Lynch syndrome.
Researchers are exploring new options for kidney cancer treatments.
Researchers at the Blood Cancer Discovery Symposium presented data on multidrug resistance and clinical trial design.